After months of nonstop euphoria for Johnson & Johnson, the stock winds have changed. It's not necessarily time to sell, but you should get protective. More
What If Microsoft’s Xbox One Is a Hit?
Microsoft has a large hill to climb with the Xbox One, but if the device succeeds, it could mean trouble for Google and Apple. More
5 Stocks With Ugly Cash Flow — KWK STP ATPG EDN AONE
This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader. More
AstraZeneca to Purchase Omthera
AstraZeneca will purchase Omertha, a make of fish-oil based pharmaceuticals as it continues to bolster its cardiovascular product lineup More
Do Income Investors Have Anywhere To Hide?
It's getting more difficult to find ways to play income in the market. Here is some advice on getting ahead of the curve for bonds and equities. More
Wendy’s Moves Forward With Pretzel Bun
Wendy's will debut a Pretzel Bacon Cheeseburger nationwide during the third quarter after successful testing in certain markets. More
3 Biopharma Runners With Fuel in the Tank
Biopharmaceutical stocks have been on a tear so far this year, but a few still have the pipeline power necessary to keep flying. More
